132 related articles for article (PubMed ID: 37301669)
1. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia).
De Las Cuevas C; Sanz EJ; de Leon J
Schizophr Res; 2024 Jun; 268():165-174. PubMed ID: 37301669
[TBL] [Abstract][Full Text] [Related]
2. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK.
De Las Cuevas C; Sanz EJ; Gross JA; Correll CU; Verdoux H; Lally J; de Filippis R; Schulte PFJ; Molden E; Arrojo-Romero M; Bostrom AD; Schoretsanitis G; Fernandez-Egea E; de Leon J
Schizophr Res; 2024 Jun; 268():175-188. PubMed ID: 38065799
[TBL] [Abstract][Full Text] [Related]
3. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance.
Sagud M; Breznoscakova D; Celofiga A; Chihai J; Chkonia E; Ristic Ignjatovic D; Injac Stevovic L; Kopecek M; Kurvits K; Kuzo N; Lazáry J; Mazaliauskienė R; Mladina Perisa D; Novotni A; Panov G; Pikirenia U; Rădulescu FȘ; Sukiasyan SG; Taube M; Tomori S; Wilkowska A; De Las Cuevas C; Sanz EJ; de Leon J
Schizophr Res; 2024 Jun; 268():53-59. PubMed ID: 37783650
[TBL] [Abstract][Full Text] [Related]
4. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance.
Baptista T; Motuca M; Serrano A; Perez Lo Presti A; Fernandez-Arana A; Olmos I; Pabon A; Yepez JGA; Alejo Galarza GJ; Rivera Ramirez NM; Elkis H; Sanz EJ; De Las Cuevas C; de Leon J
Schizophr Res; 2024 Jun; 268():60-65. PubMed ID: 37985318
[TBL] [Abstract][Full Text] [Related]
5. Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom.
de Leon J; Arrojo-Romero M; Verdoux H; Ruan CJ; Schoretsanitis G; Rohde C; Cohen D; Schulte PFJ; Kim SH; Cotes RO; Leung JG; Otsuka Y; Kirilochev OO; Baptista T; Grover S; Every-Palmer S; Clark SR; McGrane IR; Motuca M; Olmos I; Wilkowska A; Sagud M; Anil Yağcioğlu AE; Ristic DI; Lazary J; Sanz EJ; De Las Cuevas C
J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):239-245. PubMed ID: 37068034
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):238-250. PubMed ID: 36513400
[TBL] [Abstract][Full Text] [Related]
7. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
[TBL] [Abstract][Full Text] [Related]
8. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
[TBL] [Abstract][Full Text] [Related]
9. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
10. The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia: a retrospective study from real-world data (1995-2015).
Almutairi KB; Inderjeeth CA; Preen DB; Keen HI; Nossent JC
Rheumatol Int; 2024 Jun; 44(6):1089-1099. PubMed ID: 38615313
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review.
De Las Cuevas C; Arrojo-Romero M; Ruan CJ; Schoretsanitis G; Sanz EJ; de Leon J
Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):715-727. PubMed ID: 36526610
[TBL] [Abstract][Full Text] [Related]
12. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016.
Perry LT; Bhasale A; Fabbri A; Lexchin J; Puil L; Joarder M; Mintzes B
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1054-1063. PubMed ID: 32696556
[TBL] [Abstract][Full Text] [Related]
13. Data From the World Health Organization's Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions.
De Leon J; Sanz EJ; De Las Cuevas C
Schizophr Bull; 2020 Jan; 46(1):1-3. PubMed ID: 31901099
[No Abstract] [Full Text] [Related]
14. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase.
Man WH; Wilting I; Souverein P; Meyboom R; Egberts T; Heerdink ER
J Clin Psychopharmacol; 2020; 40(3):283-286. PubMed ID: 32332463
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
16. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
Liu CL; Maruf AA; Bousman CA
Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
[TBL] [Abstract][Full Text] [Related]
17. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
18. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
Svendsen K; Wood M; Olsson E; Nordeng H
Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database.
de Filippis R; De Las Cuevas C; Sanz EJ; Schoretsanitis G; Correll CU; de Leon J
Schizophr Res; 2024 Jun; 268():118-130. PubMed ID: 37981478
[TBL] [Abstract][Full Text] [Related]
20. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2021 Jul; ():. PubMed ID: 34298164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
